A broken filter: prefrontal functional connectivity abnormalities in schizophrenia during working memory interference.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMC 3879404)

Published in Schizophr Res on August 03, 2012

Authors

Alan Anticevic1, Grega Repovs, John H Krystal, Deanna M Barch

Author Affiliations

1: Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, USA. alan.anticevic@yale.edu

Articles citing this

Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. JAMA Psychiatry (2015) 1.76

Global resting-state functional magnetic resonance imaging analysis identifies frontal cortex, striatal, and cerebellar dysconnectivity in obsessive-compulsive disorder. Biol Psychiatry (2013) 1.47

The frontoparietal control system: a central role in mental health. Neuroscientist (2014) 1.13

Dissociating distractor-filtering at encoding and during maintenance. J Exp Psychol Hum Percept Perform (2014) 0.89

Mediodorsal and visual thalamic connectivity differ in schizophrenia and bipolar disorder with and without psychosis history. Schizophr Bull (2014) 0.87

Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis. BMC Psychiatry (2015) 0.80

Hyperfocusing in schizophrenia: Evidence from interactions between working memory and eye movements. J Abnorm Psychol (2014) 0.78

The impact of motivation on cognitive performance in an animal model of the negative and cognitive symptoms of schizophrenia. Behav Neurosci (2015) 0.77

Enhanced vulnerability to distraction does not account for working memory capacity reduction in people with schizophrenia. Schizophr Res Cogn (2014) 0.77

Functional neuroimaging and schizophrenia: a view towards effective connectivity modeling and polygenic risk. Dialogues Clin Neurosci (2013) 0.77

Fronto-Limbic Brain Dysfunction during the Regulation of Emotion in Schizophrenia. PLoS One (2016) 0.76

Disrupted Working Memory Circuitry in Schizophrenia: Disentangling fMRI Markers of Core Pathology vs Other Aspects of Impaired Performance. Neuropsychopharmacology (2016) 0.76

Development of White Matter Microstructure and Intrinsic Functional Connectivity Between the Amygdala and Ventromedial Prefrontal Cortex: Associations With Anxiety and Depression. Biol Psychiatry (2017) 0.76

Amygdala volume is reduced in early course schizophrenia. Psychiatry Res (2016) 0.75

Task Performance Modulates Functional Connectivity Involving the Dorsolateral Prefrontal Cortex in Patients with Schizophrenia. Front Psychol (2017) 0.75

Dynamic Connectivity between Brain Networks Supports Working Memory: Relationships to Dopamine Release and Schizophrenia. J Neurosci (2016) 0.75

Dysregulation of Specialized Delay/Interference-Dependent Working Memory Following Loss of Dysbindin-1A in Schizophrenia-Related Phenotypes. Neuropsychopharmacology (2016) 0.75

Biases in facial and vocal emotion recognition in chronic schizophrenia. Front Psychol (2014) 0.75

Transdiagnostic neural markers of emotion-cognition interaction in psychotic disorders. J Abnorm Psychol (2016) 0.75

Genetic insights into the neurodevelopmental origins of schizophrenia. Nat Rev Neurosci (2017) 0.75

Articles cited by this

AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res (1996) 53.52

The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A (2005) 37.57

Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22

The impact of global signal regression on resting state correlations: are anti-correlated networks introduced? Neuroimage (2008) 10.96

Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry (2003) 10.07

The global signal and observed anticorrelated resting state brain networks. J Neurophysiol (2009) 9.64

The episodic buffer: a new component of working memory? Trends Cogn Sci (2000) 9.16

Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry (2003) 9.05

A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage (2004) 7.72

Anatomic localization and quantitative analysis of gradient refocused echo-planar fMRI susceptibility artifacts. Neuroimage (1997) 5.70

On the relationship between emotion and cognition. Nat Rev Neurosci (2008) 5.41

Emotion processing and the amygdala: from a 'low road' to 'many roads' of evaluating biological significance. Nat Rev Neurosci (2010) 5.28

Measuring functional connectivity during distinct stages of a cognitive task. Neuroimage (2004) 4.71

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) (2001) 4.52

Prefrontal cortex and basal ganglia control access to working memory. Nat Neurosci (2007) 4.21

The mind and brain of short-term memory. Annu Rev Psychol (2008) 3.28

Working memory impairments in schizophrenia: a meta-analysis. J Abnorm Psychol (2005) 3.26

Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol (2000) 3.17

Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp (2005) 2.93

Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures. Schizophr Bull (2006) 2.92

Active maintenance in prefrontal area 46 creates distractor-resistant memory. Nat Neurosci (2002) 2.34

Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull (2007) 2.25

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol (2001) 2.12

Effects of frontal lobe damage on interference effects in working memory. Cogn Affect Behav Neurosci (2002) 2.05

Interactions between glutamatergic and monoaminergic systems within the basal ganglia--implications for schizophrenia and Parkinson's disease. Trends Neurosci (1990) 1.91

When less is more: TPJ and default network deactivation during encoding predicts working memory performance. Neuroimage (2009) 1.83

Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry (2008) 1.76

Failure of schizophrenia patients to overcome salient distractors during working memory encoding. Biol Psychiatry (2010) 1.73

Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. J Clin Psychiatry (2006) 1.69

Mechanism for top-down control of working memory capacity. Proc Natl Acad Sci U S A (2009) 1.63

A prospective study of childhood neurocognitive functioning in schizophrenic patients and their siblings. Am J Psychiatry (2003) 1.63

Cognitive and behavioral precursors of schizophrenia. Dev Psychopathol (1999) 1.60

A functional magnetic resonance imaging study of working memory abnormalities in schizophrenia. Biol Psychiatry (2006) 1.56

General and specific functional connectivity disturbances in first-episode schizophrenia during cognitive control performance. Biol Psychiatry (2011) 1.54

Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophr Bull (2006) 1.53

Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophr Bull (2009) 1.50

Resisting emotional interference: brain regions facilitating working memory performance during negative distraction. Cogn Affect Behav Neurosci (2010) 1.44

Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res (2007) 1.34

Schizophrenia: a subcortical neurotransmitter imbalance syndrome? Schizophr Bull (1990) 1.20

Delay-period activity in the prefrontal cortex: one function is sensory gating. J Cogn Neurosci (2005) 1.19

Emotion effects on attention, amygdala activation, and functional connectivity in schizophrenia. Schizophr Bull (2011) 1.17

Impaired modulation of attention and emotion in schizophrenia. Schizophr Bull (2008) 1.15

Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: an fMRI study. Neuropsychologia (2007) 1.10

Thalamic pathology in schizophrenia. Curr Top Behav Neurosci (2010) 1.05

Negative and nonemotional interference with visual working memory in schizophrenia. Biol Psychiatry (2011) 0.99

Working memory encoding and maintenance deficits in schizophrenia: neural evidence for activation and deactivation abnormalities. Schizophr Bull (2011) 0.98

Working memory overload: fronto-limbic interactions and effects on subsequent working memory function. Brain Imaging Behav (2010) 0.88

Hurry up and wait: action, distraction, and inhibition in schizophrenia. Biol Psychiatry (2011) 0.77

Articles by these authors

The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry (2008) 9.00

Prediction of individual brain maturity using fMRI. Science (2010) 7.29

The maturing architecture of the brain's default network. Proc Natl Acad Sci U S A (2008) 7.28

Development of distinct control networks through segregation and integration. Proc Natl Acad Sci U S A (2007) 6.85

Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry (2004) 6.05

The WU-Minn Human Connectome Project: an overview. Neuroimage (2013) 5.49

Identification of separable cognitive factors in schizophrenia. Schizophr Res (2004) 5.34

Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol Psychiatry (2004) 4.46

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46

Social supports and serotonin transporter gene moderate depression in maltreated children. Proc Natl Acad Sci U S A (2004) 4.42

The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A (2009) 4.05

Brain-derived neurotrophic factor-5-HTTLPR gene interactions and environmental modifiers of depression in children. Biol Psychiatry (2006) 3.97

Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry (2004) 3.64

Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med (2011) 3.36

Treatment course with antidepressant therapy in late-life depression. Am J Psychiatry (2012) 2.94

Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull (2007) 2.94

Multi-task connectivity reveals flexible hubs for adaptive task control. Nat Neurosci (2013) 2.79

Altered emotional interference processing in affective and cognitive-control brain circuitry in major depression. Biol Psychiatry (2007) 2.61

A prospective cohort study investigating factors associated with depression during medical internship. Arch Gen Psychiatry (2010) 2.41

The role of default network deactivation in cognition and disease. Trends Cogn Sci (2012) 2.39

A theory of cognitive control, aging cognition, and neuromodulation. Neurosci Biobehav Rev (2002) 2.37

A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry (2003) 2.36

Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry (2005) 2.36

Association between alcoholism and gamma-amino butyric acid alpha2 receptor subtype in a Russian population. Alcohol Clin Exp Res (2005) 2.35

Flexible neural mechanisms of cognitive control within human prefrontal cortex. Proc Natl Acad Sci U S A (2009) 2.26

BOLD correlates of trial-by-trial reaction time variability in gray and white matter: a multi-study fMRI analysis. PLoS One (2009) 2.25

Cognitive control, goal maintenance, and prefrontal function in healthy aging. Cereb Cortex (2007) 2.18

A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry (2008) 2.17

Toward open sharing of task-based fMRI data: the OpenfMRI project. Front Neuroinform (2013) 2.17

Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry (2005) 2.17

Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors. Biol Psychiatry (2010) 2.16

Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry (2003) 2.15

Global connectivity of prefrontal cortex predicts cognitive control and intelligence. J Neurosci (2012) 2.10

Cost and cost-effectiveness in a randomized trial of long-acting risperidone for schizophrenia. J Clin Psychiatry (2012) 2.10

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry (2009) 2.09

Functional connectomics from resting-state fMRI. Trends Cogn Sci (2013) 2.05

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch Gen Psychiatry (2002) 2.01

Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry (2002) 1.99

A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry (2010) 1.99

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry (2004) 1.96

Thalamic shape abnormalities in individuals with schizophrenia and their nonpsychotic siblings. J Neurosci (2007) 1.95

Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biol Psychiatry (2006) 1.92

Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86

When less is more: TPJ and default network deactivation during encoding predicts working memory performance. Neuroimage (2009) 1.83

Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia Initiative. Biol Psychiatry (2008) 1.81

Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry (2003) 1.81

The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res (2011) 1.80

Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence. Biol Psychiatry (2011) 1.76

Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry (2008) 1.76

Transient BOLD responses at block transitions. Neuroimage (2005) 1.76

Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings. Br J Psychiatry (2010) 1.73

Abnormal hemodynamics in schizophrenia during an auditory oddball task. Biol Psychiatry (2005) 1.72

Support for the vascular depression hypothesis in late-life depression: results of a 2-site, prospective, antidepressant treatment trial. Arch Gen Psychiatry (2010) 1.72

Brain network connectivity in individuals with schizophrenia and their siblings. Biol Psychiatry (2010) 1.71

Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry (2003) 1.70

Impaired visual cortical plasticity in schizophrenia. Biol Psychiatry (2012) 1.67

Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology (Berl) (2005) 1.67

Clinical, functional, and intertask correlations of measures developed by the Cognitive Neuroscience Test Reliability and Clinical Applications for Schizophrenia Consortium. Schizophr Bull (2011) 1.67

Rare ADH variant constellations are specific for alcohol dependence. Alcohol Alcohol (2012) 1.66

Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry (2003) 1.64

Nicotine effects on brain function and functional connectivity in schizophrenia. Biol Psychiatry (2004) 1.64

Global prefrontal and fronto-amygdala dysconnectivity in bipolar I disorder with psychosis history. Biol Psychiatry (2012) 1.62

Ketamine and the potential role for rapid-acting antidepressant medications. Swiss Med Wkly (2007) 1.62

Genetic and environmental predictors of early alcohol use. Biol Psychiatry (2006) 1.60

Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators. Biol Psychiatry (2009) 1.55

Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann Neurol (2005) 1.55

Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry (2005) 1.55

Antidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depression. J Affect Disord (2008) 1.53

Factors mediating cognitive deficits and psychopathology among siblings of individuals with schizophrenia. Schizophr Bull (2006) 1.53

Human Connectome Project informatics: quality control, database services, and data visualization. Neuroimage (2013) 1.53

Glutamate metabolism in major depressive disorder. Am J Psychiatry (2014) 1.52

Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meeting. Schizophr Bull (2008) 1.52

Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry (2005) 1.52

Variable global dysconnectivity and individual differences in schizophrenia. Biol Psychiatry (2011) 1.51

Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms. Biol Psychiatry (2006) 1.51

Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull (2012) 1.50

Regional white matter hyperintensity burden in automated segmentation distinguishes late-life depressed subjects from comparison subjects matched for vascular risk factors. Am J Psychiatry (2008) 1.50

Genome-wide association study of alcohol dependence implicates KIAA0040 on chromosome 1q. Neuropsychopharmacology (2011) 1.50

Striking differences in glucose and lactate levels between brain extracellular fluid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab (2002) 1.48

Maternal support in early childhood predicts larger hippocampal volumes at school age. Proc Natl Acad Sci U S A (2012) 1.48

Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry (2006) 1.47

Anhedonia and the experience of emotion in individuals with schizophrenia. J Abnorm Psychol (2007) 1.47

Preliminary evidence for persistent abnormalities in amygdala volumes in adolescents and young adults with bipolar disorder. Bipolar Disord (2005) 1.47

CNTRICS final task selection: social cognitive and affective neuroscience-based measures. Schizophr Bull (2008) 1.46

Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biol Psychiatry (2004) 1.44

Resisting emotional interference: brain regions facilitating working memory performance during negative distraction. Cogn Affect Behav Neurosci (2010) 1.44

Catatonia in DSM-5. Schizophr Res (2013) 1.43

Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx (2006) 1.43

Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking. Biol Psychiatry (2007) 1.42

Corpus callosum in maltreated children with posttraumatic stress disorder: a diffusion tensor imaging study. Psychiatry Res (2008) 1.42

Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med (2014) 1.39

Extracting core components of cognitive control. Trends Cogn Sci (2006) 1.37

Clinical studies implementing glutamate neurotransmission in mood disorders. Ann N Y Acad Sci (2003) 1.35

Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry (2002) 1.34

Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cereb Cortex (2007) 1.34

Glutamatergic model psychoses: prediction error, learning, and inference. Neuropsychopharmacology (2010) 1.34